This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Polydactyly
Q17_POLYDACTYLY
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
45 |
4. Check minimum number of eventsNone |
45 |
5. Include endpointsNone |
45 |
6. Filter based on genotype QC (FinnGen only) |
45 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Polydactylia
Similar endpoints
↥List of similar endpoints to
Polydactyly
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2140 | 940 | 1200 |
| Only index persons | 1229 | 549 | 680 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | - | 0.37 | 0.30 |
| Only index persons | 0.81 | 1.03 | 0.64 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 45 | 24 | 21 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 3.58 | 6.28 | 0.49 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
44
0.00
1.62
0.0
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
15
3.61
1.56
2.6
2.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
10
46
2.51
1.53
3.8
3.5
mg/mmol
1.1
12.1
—
5
27
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
24
2.72
1.35
1.7
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
0
34
0.00
1.22
0.0
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
20
2.68
1.18
2.4
3.0
pmol/l
5.2
4.7
—
5
15
(3020961) Endomysium IgA Ab [Titer] in Serum
7
36
2.11
1.02
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
29
0.00
1.02
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
29
0.00
1.02
0.0
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
28
0.00
1.01
0.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
113
0.46
1.01
1.3
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
24
0.00
0.82
0.0
2.0
—
220.8
—
0
10
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
24
0.00
0.82
0.0
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
25
0.00
0.82
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
26
0.00
0.81
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
26
0.00
0.81
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
27
0.00
0.80
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
27
0.00
0.80
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
27
0.00
0.80
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
27
0.00
0.80
0.0
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
12
77
1.76
0.78
1.6
1.6
pmol/l
112.1
100.8
—
6
43
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
19
0.00
0.62
0.0
23.2
—
122.7
—
0
19
(3003327) Ova and parasites identified in Stool by Light microscopy
0
21
0.00
0.62
0.0
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
21
254
0.68
0.57
3.5
3.3
mmol/l
4.6
4.4
0.77
21
236
(40760892) CBC W Ordered Manual Differential panel - Blood
12
84
1.58
0.56
4.8
5.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
9
125
0.65
0.53
1.3
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
166
0.70
0.44
1.5
2.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
12
89
1.47
0.43
4.7
2.5
mmol/l
6.2
8.9
0.75
12
83
(40768804) Tissue Pathology biopsy report
12
89
1.47
0.43
1.9
1.8
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
15
0.00
0.42
0.0
1.8
—
24.7
—
0
15
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
16
0.00
0.42
0.0
57.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
18
216
0.72
0.41
4.9
3.6
mmol/mol
35.7
36.2
0.09
18
197
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
17
0.00
0.41
0.0
1.7
—
0.2
—
0
10
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
17
0.00
0.41
0.0
24.5
—
0.7
—
0
17
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
18
0.00
0.41
0.0
23.3
—
1.1
—
0
18
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.41
0.0
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
18
0.00
0.41
0.0
1.7
—
399.5
—
0
10
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
18
0.00
0.41
0.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
40
372
1.68
0.40
9.2
9.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
15
120
1.38
0.36
8.5
2.9
e6/l
82.8
25.0
—
10
83
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
6
46
1.35
0.34
8.3
14.5
mmol/l
24.0
23.9
—
6
46
(36304419) Bacteria [Presence] in Urine
12
93
1.40
0.34
9.2
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
10
129
0.71
0.34
1.7
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
109
0.68
0.34
7.9
3.2
—
—
—
0
0
(3015736) pH of Urine
10
128
0.72
0.32
4.0
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
35
373
0.72
0.29
3.2
3.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
19
163
1.29
0.28
3.6
3.0
ug/l
50.2
74.5
0.63
19
149
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
75
1.25
0.27
3.4
3.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11
135
0.75
0.26
5.0
5.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
5
38
1.35
0.24
2.2
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
5
42
1.21
0.22
1.2
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
5.6
—
3.5
—
0
11
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
5.0
—
0
11
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
11
0.00
0.21
0.0
46.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
1.8
—
0
5
(3024928) Oxygen saturation in Venous blood
0
10
0.00
0.21
0.0
36.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
35.9
—
0
10
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
5.3
—
293.2
—
0
12
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020891) Body temperature
0
12
0.00
0.21
0.0
7.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
14
0.00
0.20
0.0
6.6
—
64.6
—
0
14
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
6.5
—
22.7
—
0
14
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
3.7
—
0
7
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
111
1.24
0.18
9.2
2.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
7
62
1.15
0.18
2.6
4.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
38
362
1.32
0.16
14.0
15.8
%
39.1
39.7
0.34
32
316
(3001604) Monocytes [#/volume] in Blood
22
201
1.18
0.16
6.0
9.1
e9/l
0.5
0.5
0.12
17
176
(42870588) Differential panel, method unspecified - Blood
15
134
1.18
0.13
8.4
11.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
20
216
0.87
0.12
6.8
3.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
5
45
1.12
0.10
1.8
1.3
nmol/l
24.1
19.3
—
5
40
(3012544) pH of Venous blood
6
57
1.06
0.09
8.5
14.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
69
0.85
0.08
1.5
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
8
77
1.05
0.08
7.3
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
9
84
1.09
0.07
7.3
2.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
11
100
1.13
0.06
3.5
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
10
110
0.88
0.05
11.7
8.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
35
359
0.89
0.04
12.1
12.1
mg/l
41.5
20.7
1.20
22
253
(3044889) 12 lead EKG panel
16
168
0.93
0.03
2.9
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
106
0.93
0.01
2.3
2.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
58
1.04
0.00
10.3
15.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.4
—
805.0
—
0
5
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
96.1
—
0
8
(3000093) Morphology [Interpretation] in Blood Narrative
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
10.0
—
1597.0
—
0
5
(3011397) Hemoglobin [Presence] in Urine by Test strip
9
88
1.03
0.00
2.0
3.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
42.8
—
0
6
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.0
—
0.6
—
0
5
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.4
—
1.5
—
0
5
(4062490)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3011985) Renin [Units/volume] in Plasma
0
6
0.00
0.00
0.0
1.0
—
23.7
—
0
6
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
28.8
—
0
8
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
7.5
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
3.0
—
214.2
—
0
5
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
84
0.94
0.00
1.5
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
86
0.92
0.00
1.8
1.8
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
2.5
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
8
0.00
0.00
0.0
6.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
100
1.00
0.00
2.3
2.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
64.0
—
0
5
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
18.8
—
0
5
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(44790047)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
0.2
—
0
5
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
0
8
0.00
0.00
0.0
62.3
—
1.6
—
0
8
(44806118)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
7
0.00
0.00
0.0
71.3
—
1.0
—
0
7
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(4268621)
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(44790048)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
8
0.00
0.00
0.0
1.1
—
152.3
—
0
8
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
48.3
—
12.3
—
0
7
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44790049)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_POLYDACTYLY and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_POLYDACTYLY.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_POLYDACTYLY – Polydactyly
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data